Skip to content

SCHEDULE 13G/AAccepted Feb 13, 5:25 PM ET

Maze Therapeutics, Inc. SCHEDULE 13G/A

Third Rock Ventures IV, L.P.

Accepted (ET)

5:25 PM

Feb 13, 2026

Filed

Feb 13, 2026

Documents

1

Size

15.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.